 Marie Burdine
Concepts (163)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA-Activated Protein Kinase | 4 | 2023 | 23 | 2.620 |
Why?
| | DNA-Binding Proteins | 3 | 2021 | 462 | 1.330 |
Why?
| | Early Growth Response Protein 1 | 1 | 2021 | 39 | 0.810 |
Why?
| | Chromones | 1 | 2021 | 16 | 0.800 |
Why?
| | Graft Survival | 2 | 2022 | 165 | 0.800 |
Why?
| | Graft Rejection | 2 | 2022 | 161 | 0.780 |
Why?
| | Lymphocyte Activation | 1 | 2021 | 197 | 0.780 |
Why?
| | Morpholines | 1 | 2021 | 64 | 0.770 |
Why?
| | Skin Transplantation | 1 | 2021 | 50 | 0.770 |
Why?
| | Pancreatic Neoplasms | 3 | 2012 | 234 | 0.690 |
Why?
| | T-Lymphocytes | 1 | 2021 | 373 | 0.680 |
Why?
| | Antineoplastic Agents | 1 | 2023 | 1300 | 0.490 |
Why?
| | Blood Preservation | 2 | 2012 | 29 | 0.490 |
Why?
| | Plasma | 2 | 2012 | 52 | 0.470 |
Why?
| | Mice | 10 | 2023 | 6413 | 0.430 |
Why?
| | Blood Component Transfusion | 1 | 2010 | 8 | 0.380 |
Why?
| | Mice, Inbred BALB C | 2 | 2021 | 368 | 0.380 |
Why?
| | Extracellular Matrix Proteins | 1 | 2010 | 75 | 0.360 |
Why?
| | GATA4 Transcription Factor | 3 | 2008 | 13 | 0.340 |
Why?
| | Animals | 12 | 2023 | 14385 | 0.330 |
Why?
| | Recombinant Proteins | 1 | 2010 | 569 | 0.320 |
Why?
| | Reactive Oxygen Species | 1 | 2010 | 491 | 0.310 |
Why?
| | Cytokines | 2 | 2021 | 676 | 0.240 |
Why?
| | T-Box Domain Proteins | 2 | 2008 | 14 | 0.230 |
Why?
| | Proteomics | 2 | 2017 | 343 | 0.230 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 116 | 0.210 |
Why?
| | Jurkat Cells | 1 | 2021 | 34 | 0.210 |
Why?
| | Protein Stability | 1 | 2021 | 44 | 0.200 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 180 | 0.200 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 99 | 0.200 |
Why?
| | Mice, SCID | 1 | 2021 | 196 | 0.200 |
Why?
| | Mutation, Missense | 1 | 2021 | 117 | 0.200 |
Why?
| | Kidney Transplantation | 1 | 2022 | 188 | 0.190 |
Why?
| | DNA | 2 | 2023 | 581 | 0.190 |
Why?
| | Transcription, Genetic | 1 | 2021 | 418 | 0.180 |
Why?
| | GATA6 Transcription Factor | 1 | 2008 | 3 | 0.170 |
Why?
| | Cell Line, Tumor | 3 | 2015 | 1550 | 0.160 |
Why?
| | Flow Cytometry | 1 | 2021 | 546 | 0.160 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 1999 | 0.150 |
Why?
| | Blood Proteins | 1 | 2017 | 100 | 0.150 |
Why?
| | Heart Defects, Congenital | 2 | 2008 | 608 | 0.140 |
Why?
| | Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.140 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.140 |
Why?
| | Whole-Body Irradiation | 1 | 2017 | 160 | 0.140 |
Why?
| | Autoantigens | 1 | 2016 | 64 | 0.140 |
Why?
| | Heart | 1 | 2008 | 360 | 0.140 |
Why?
| | Cell Proliferation | 2 | 2010 | 1096 | 0.140 |
Why?
| | Endoplasmic Reticulum | 1 | 2016 | 123 | 0.130 |
Why?
| | Proteome | 1 | 2017 | 178 | 0.130 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2015 | 27 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-ret | 1 | 2015 | 35 | 0.130 |
Why?
| | Disease Models, Animal | 1 | 2021 | 1639 | 0.130 |
Why?
| | Protein Processing, Post-Translational | 1 | 2016 | 183 | 0.130 |
Why?
| | Collagen | 1 | 2016 | 223 | 0.130 |
Why?
| | Heart Diseases | 1 | 2007 | 237 | 0.120 |
Why?
| | Mutation | 4 | 2012 | 1501 | 0.120 |
Why?
| | Nuclear Proteins | 1 | 2015 | 252 | 0.120 |
Why?
| | Thyroid Neoplasms | 1 | 2015 | 162 | 0.110 |
Why?
| | Macaca | 1 | 2012 | 7 | 0.110 |
Why?
| | Sirtuin 1 | 1 | 2012 | 29 | 0.110 |
Why?
| | Humans | 9 | 2023 | 54246 | 0.110 |
Why?
| | Erythrocyte Transfusion | 1 | 2012 | 74 | 0.100 |
Why?
| | Diet, High-Fat | 1 | 2012 | 216 | 0.090 |
Why?
| | Injections, Intravenous | 1 | 2010 | 148 | 0.090 |
Why?
| | Transcription Factors | 2 | 2005 | 622 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2010 | 68 | 0.090 |
Why?
| | Fibronectins | 1 | 2010 | 41 | 0.090 |
Why?
| | Histones | 1 | 2012 | 335 | 0.090 |
Why?
| | Protein Binding | 2 | 2010 | 736 | 0.090 |
Why?
| | Neoplasm Metastasis | 1 | 2010 | 252 | 0.090 |
Why?
| | Peritoneal Neoplasms | 1 | 2010 | 60 | 0.090 |
Why?
| | Lymphatic Metastasis | 1 | 2010 | 256 | 0.090 |
Why?
| | Cell Movement | 1 | 2010 | 271 | 0.090 |
Why?
| | Neovascularization, Pathologic | 1 | 2010 | 168 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2012 | 151 | 0.080 |
Why?
| | Endothelial Cells | 1 | 2010 | 294 | 0.080 |
Why?
| | Fibroblasts | 1 | 2010 | 386 | 0.080 |
Why?
| | Antioxidants | 1 | 2010 | 297 | 0.080 |
Why?
| | Heart Valve Diseases | 1 | 2005 | 42 | 0.060 |
Why?
| | Receptors, Cell Surface | 1 | 2005 | 130 | 0.060 |
Why?
| | Oxidative Stress | 1 | 2010 | 958 | 0.060 |
Why?
| | Aortic Valve | 1 | 2005 | 113 | 0.060 |
Why?
| | COS Cells | 3 | 2012 | 78 | 0.060 |
Why?
| | Apoptosis | 1 | 2010 | 1300 | 0.060 |
Why?
| | Mass Spectrometry | 2 | 2017 | 313 | 0.060 |
Why?
| | Xenopus Proteins | 1 | 2003 | 29 | 0.060 |
Why?
| | Delayed Graft Function | 1 | 2022 | 11 | 0.060 |
Why?
| | Cold Ischemia | 1 | 2022 | 11 | 0.060 |
Why?
| | Creatinine | 1 | 2022 | 169 | 0.050 |
Why?
| | HeLa Cells | 2 | 2008 | 291 | 0.050 |
Why?
| | Base Sequence | 2 | 2007 | 719 | 0.050 |
Why?
| | Embryo Loss | 1 | 2008 | 2 | 0.040 |
Why?
| | Signal Transduction | 2 | 2017 | 1753 | 0.040 |
Why?
| | Fetal Growth Retardation | 1 | 2008 | 45 | 0.040 |
Why?
| | Pregnancy | 2 | 2012 | 2620 | 0.040 |
Why?
| | Alleles | 1 | 2008 | 277 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2008 | 137 | 0.040 |
Why?
| | Conserved Sequence | 1 | 2007 | 57 | 0.040 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 124 | 0.040 |
Why?
| | Genotype | 1 | 2008 | 599 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2017 | 106 | 0.040 |
Why?
| | Exons | 1 | 2007 | 105 | 0.040 |
Why?
| | Gamma Rays | 1 | 2017 | 56 | 0.040 |
Why?
| | Family Health | 1 | 2007 | 83 | 0.040 |
Why?
| | Transcriptional Activation | 1 | 2007 | 134 | 0.040 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2017 | 204 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2017 | 249 | 0.040 |
Why?
| | Cyclophilins | 1 | 2016 | 13 | 0.040 |
Why?
| | Hydroxylation | 1 | 2016 | 61 | 0.040 |
Why?
| | Genetic Testing | 1 | 2007 | 135 | 0.040 |
Why?
| | Osteogenesis Imperfecta | 1 | 2016 | 39 | 0.030 |
Why?
| | Myocardium | 1 | 2008 | 441 | 0.030 |
Why?
| | Extracellular Matrix | 1 | 2016 | 111 | 0.030 |
Why?
| | Female | 5 | 2012 | 28418 | 0.030 |
Why?
| | Pedigree | 2 | 2005 | 146 | 0.030 |
Why?
| | DNA Mutational Analysis | 2 | 2005 | 217 | 0.030 |
Why?
| | Phosphorylation | 1 | 2015 | 614 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2016 | 926 | 0.030 |
Why?
| | p300-CBP Transcription Factors | 1 | 2012 | 5 | 0.030 |
Why?
| | Cell Line | 1 | 2016 | 1153 | 0.030 |
Why?
| | Catalytic Domain | 1 | 2012 | 62 | 0.030 |
Why?
| | Acetylation | 1 | 2012 | 99 | 0.030 |
Why?
| | Indoles | 1 | 2015 | 289 | 0.030 |
Why?
| | Histone Deacetylases | 1 | 2012 | 47 | 0.030 |
Why?
| | Substrate Specificity | 1 | 2012 | 209 | 0.030 |
Why?
| | Bone and Bones | 1 | 2016 | 516 | 0.030 |
Why?
| | Platelet-Derived Growth Factor | 1 | 2012 | 23 | 0.030 |
Why?
| | Lysine | 1 | 2012 | 102 | 0.030 |
Why?
| | Chemokine CCL2 | 1 | 2012 | 78 | 0.030 |
Why?
| | Erythrocytes | 1 | 2012 | 98 | 0.030 |
Why?
| | Neoplasms, Experimental | 1 | 2012 | 115 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 314 | 0.020 |
Why?
| | Tumor Cells, Cultured | 1 | 2012 | 477 | 0.020 |
Why?
| | Fetus | 1 | 2012 | 227 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 683 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 673 | 0.020 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2015 | 866 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2022 | 6432 | 0.020 |
Why?
| | Male | 4 | 2012 | 27312 | 0.020 |
Why?
| | Time Factors | 1 | 2017 | 3212 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 434 | 0.020 |
Why?
| | Blood Platelets | 1 | 2012 | 269 | 0.020 |
Why?
| | Adenocarcinoma | 1 | 2012 | 428 | 0.020 |
Why?
| | Liver | 1 | 2012 | 1225 | 0.020 |
Why?
| | Lod Score | 1 | 2005 | 7 | 0.020 |
Why?
| | Receptor, Notch1 | 1 | 2005 | 4 | 0.020 |
Why?
| | Chromosomes, Human, Pair 9 | 1 | 2005 | 20 | 0.020 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 48 | 0.020 |
Why?
| | In Situ Hybridization | 1 | 2005 | 82 | 0.020 |
Why?
| | Calcinosis | 1 | 2005 | 61 | 0.020 |
Why?
| | Repressor Proteins | 1 | 2005 | 165 | 0.010 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2003 | 17 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2003 | 39 | 0.010 |
Why?
| | Frameshift Mutation | 1 | 2003 | 17 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2003 | 74 | 0.010 |
Why?
| | Homeodomain Proteins | 1 | 2003 | 82 | 0.010 |
Why?
| | Chromosome Mapping | 1 | 2003 | 175 | 0.010 |
Why?
| | Neoplasm Proteins | 1 | 2005 | 359 | 0.010 |
Why?
| | Binding Sites | 1 | 2003 | 440 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 820 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2005 | 1202 | 0.010 |
Why?
| | Child | 1 | 2005 | 7337 | 0.010 |
Why?
| | Adult | 1 | 2005 | 14182 | 0.010 |
Why?
|
|
Burdine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|